Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA).

Pinzi L, Lherbet C, Baltas M, Pellati F, Rastelli G.

Molecules. 2019 Jul 15;24(14). pii: E2567. doi: 10.3390/molecules24142567.

2.

Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-Targets.

Stevanovic S, Sencanski M, Danel M, Menendez C, Belguedj R, Bouraiou A, Nikolic K, Cojean S, Loiseau PM, Glisic S, Baltas M, García-Sosa AT.

Molecules. 2019 Apr 2;24(7). pii: E1282. doi: 10.3390/molecules24071282.

3.

Synthesis and biological evaluation of diarylheptanoids as potential antioxidant and anti-inflammatory agents.

Maurent K, Vanucci-Bacqué C, Baltas M, Nègre-Salvayre A, Augé N, Bedos-Belval F.

Eur J Med Chem. 2018 Jan 20;144:289-299. doi: 10.1016/j.ejmech.2017.12.033. Epub 2017 Dec 11.

PMID:
29275229
4.

Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity.

Oliveira PFM, Guidetti B, Chamayou A, André-Barrès C, Madacki J, Korduláková J, Mori G, Orena BS, Chiarelli LR, Pasca MR, Lherbet C, Carayon C, Massou S, Baron M, Baltas M.

Molecules. 2017 Sep 1;22(9). pii: E1457. doi: 10.3390/molecules22091457.

5.

4-Hydroxynonenal Contributes to Angiogenesis through a Redox-Dependent Sphingolipid Pathway: Prevention by Hydralazine Derivatives.

Camaré C, Vanucci-Bacqué C, Augé N, Pucelle M, Bernis C, Swiader A, Baltas M, Bedos-Belval F, Salvayre R, Nègre-Salvayre A.

Oxid Med Cell Longev. 2017;2017:9172741. doi: 10.1155/2017/9172741. Epub 2017 Apr 5.

6.

Total Synthesis of Tedarene A.

Maurent K, Vanucci-Bacqué C, Saffon-Merceron N, Baltas M, Bedos-Belval F.

J Nat Prod. 2017 May 26;80(5):1623-1630. doi: 10.1021/acs.jnatprod.7b00199. Epub 2017 May 2.

PMID:
28463511
7.

Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis.

Matviiuk T, Madacki J, Mori G, Orena BS, Menendez C, Kysil A, André-Barrès C, Rodriguez F, Korduláková J, Mallet-Ladeira S, Voitenko Z, Pasca MR, Lherbet C, Baltas M.

Eur J Med Chem. 2016 Nov 10;123:462-475. doi: 10.1016/j.ejmech.2016.07.028. Epub 2016 Jul 16.

PMID:
27490025
8.

Synthesis and evaluation of antioxidant phenolic diaryl hydrazones as potent antiangiogenic agents in atherosclerosis.

Vanucci-Bacqué C, Camare C, Carayon C, Bernis C, Baltas M, Nègre-Salvayre A, Bedos-Belval F.

Bioorg Med Chem. 2016 Aug 15;24(16):3571-8. doi: 10.1016/j.bmc.2016.05.067. Epub 2016 May 30.

PMID:
27288181
9.

Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular Activity.

Veau D, Krykun S, Mori G, Orena BS, Pasca MR, Frongia C, Lobjois V, Chassaing S, Lherbet C, Baltas M.

ChemMedChem. 2016 May 19;11(10):1078-89. doi: 10.1002/cmdc.201600085. Epub 2016 Apr 21.

PMID:
27097919
10.

Identification and optimization of hydrazone-gallate derivatives as specific inhibitors of DNA methyltransferase 3A.

Erdmann A, Menon Y, Gros C, Masson V, Aussagues Y, Ausseil F, Novosad N, Schambel P, Baltas M, Arimondo PB.

Future Med Chem. 2016;8(4):373-80. doi: 10.4155/fmc.15.192. Epub 2016 Mar 15.

PMID:
26976348
11.

Structure-Based Virtual Ligand Screening on the XRCC4/DNA Ligase IV Interface.

Menchon G, Bombarde O, Trivedi M, Négrel A, Inard C, Giudetti B, Baltas M, Milon A, Modesti M, Czaplicki G, Calsou P.

Sci Rep. 2016 Mar 11;6:22878. doi: 10.1038/srep22878.

12.

Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth.

Chollet A, Mori G, Menendez C, Rodriguez F, Fabing I, Pasca MR, Madacki J, Korduláková J, Constant P, Quémard A, Bernardes-Génisson V, Lherbet C, Baltas M.

Eur J Med Chem. 2015 Aug 28;101:218-35. doi: 10.1016/j.ejmech.2015.06.035. Epub 2015 Jun 20.

PMID:
26142487
13.

Crystal structure of the enoyl-ACP reductase of Mycobacterium tuberculosis (InhA) in the apo-form and in complex with the active metabolite of isoniazid pre-formed by a biomimetic approach.

Chollet A, Mourey L, Lherbet C, Delbot A, Julien S, Baltas M, Bernadou J, Pratviel G, Maveyraud L, Bernardes-Génisson V.

J Struct Biol. 2015 Jun;190(3):328-37. doi: 10.1016/j.jsb.2015.04.008. Epub 2015 Apr 17.

PMID:
25891098
14.

Small molecules inhibitors of plasminogen activator inhibitor-1 - an overview.

Rouch A, Vanucci-Bacqué C, Bedos-Belval F, Baltas M.

Eur J Med Chem. 2015 Mar 6;92:619-36. doi: 10.1016/j.ejmech.2015.01.010. Epub 2015 Jan 8. Review.

PMID:
25615797
15.

Antimalarial bicyclic peroxides belonging to the G-factor family: mechanistic aspects of their formation and iron (II) induced reduction.

Ruiz J, Azema J, Payrastre C, Baltas M, Tuccio B, Vial H, Andre-Barres C.

Curr Top Med Chem. 2014;14(14):1668-83.

PMID:
25116578
16.

Synthesis, antioxidant and cytoprotective evaluation of potential antiatherogenic phenolic hydrazones. A structure-activity relationship insight.

Vanucci-Bacqué C, Carayon C, Bernis C, Camare C, Nègre-Salvayre A, Bedos-Belval F, Baltas M.

Bioorg Med Chem. 2014 Aug 1;22(15):4269-76. doi: 10.1016/j.bmc.2014.05.034. Epub 2014 May 23.

PMID:
24924425
17.

Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis.

Matviiuk T, Mori G, Lherbet C, Rodriguez F, Pasca MR, Gorichko M, Guidetti B, Voitenko Z, Baltas M.

Eur J Med Chem. 2014 Jan;71:46-52. doi: 10.1016/j.ejmech.2013.10.069. Epub 2013 Nov 4.

PMID:
24269516
18.

Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.

Matviiuk T, Rodriguez F, Saffon N, Mallet-Ladeira S, Gorichko M, de Jesus Lopes Ribeiro AL, Pasca MR, Lherbet C, Voitenko Z, Baltas M.

Eur J Med Chem. 2013;70:37-48. doi: 10.1016/j.ejmech.2013.09.041. Epub 2013 Oct 2.

PMID:
24140915
19.

Synthesis and evaluation of α-ketotriazoles and α,β-diketotriazoles as inhibitors of Mycobacterium tuberculosis.

Menendez C, Rodriguez F, Ribeiro AL, Zara F, Frongia C, Lobjois V, Saffon N, Pasca MR, Lherbet C, Baltas M.

Eur J Med Chem. 2013 Nov;69:167-73. doi: 10.1016/j.ejmech.2013.06.042. Epub 2013 Jul 8.

PMID:
24016834
20.

2-(9H-Fluoren-9-yl)-4-(4-fluoro-anilino)-4-oxo-butanoic acid.

Matviiuk T, Baltas M, Voitenko Z, Gorichko M, Lherbet C.

Acta Crystallogr Sect E Struct Rep Online. 2013 May 25;69(Pt 6):o963. doi: 10.1107/S1600536813013779. Print 2013 Jun 1.

Supplemental Content

Loading ...
Support Center